A Randomized Control Trial of Stress Management for Caregivers of Stem Cell Transplant Patients: Effect on Patient Quality of Life and Caregiver Distress
Overview
Psychology
Authors
Affiliations
Background: Psychological interventions reduce caregiver distress (CG-distress). Less distress in caregivers may contribute to improved patient quality of life (QoL), but empirical evidence is lacking. Will a caregiver stress management intervention improve patient QoL?
Methods: In this replication study, we randomized 155 allogeneic hematopoietic stem cell transplant (Allo-HSCT) patients and caregivers to PsychoEducation, Paced Respiration, and Relaxation (PEPRR) or enhanced treatment as usual (eTAU). We provided PEPRR over 3 months following transplant. Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) evaluated patient QoL, and CG-distress was based on depressive, anxious, and stress symptoms. Hierarchical linear models tested intervention, time, and interactions as fixed effects with participant as random effects.
Results: Patients whose caregivers received PEPRR did not differ on FACT-BMT between baseline and 6 months (mean = +3.74; 95% CI, -3.54 to 11.02) compared with patients of caregivers in eTAU (mean = +3.16; 95% CI, -2.88 to 9.20) even though CG-distress was decreased by PEPRR (mean = -0.23; 95% CI, -0.448 to -0.010) compared with those receiving eTAU (mean = +0.27; 95% CI, 0.033-0.504) at 6 months.
Conclusions: PEPRR reduced CG-distress without affecting their patient's FACT-BMT score. The FACT-BMT may not have distinguished unique psychological changes associated with their caregiver receiving PEPRR.
Huang Y, Li S, Lu X, Chen W, Zhang Y Healthcare (Basel). 2024; 12(21).
PMID: 39517362 PMC: 11544912. DOI: 10.3390/healthcare12212151.
Shchaslyvyi A, Antonenko S, Telegeev G Int J Environ Res Public Health. 2024; 21(8).
PMID: 39200687 PMC: 11353953. DOI: 10.3390/ijerph21081077.
Ruchiwit M, Vuthiarpa S, Ruchiwit K, Muijeen K, Phanphairoj K Clin Pract Epidemiol Ment Health. 2024; 20:e17450179276691.
PMID: 38660573 PMC: 11037511. DOI: 10.2174/0117450179276691231229071003.
Mirhosseini S, Grimwood S, Basirinezhad M, Montazeri R, Ebrahimi H Health Sci Rep. 2022; 5(6):e942.
PMID: 36439040 PMC: 9682207. DOI: 10.1002/hsr2.942.
Biobehavioral Implications of Covid-19 for Transplantation and Cellular Therapy Recipients.
Knight J, Taylor M, Rentscher K, Henley E, Uttley H, Nelson A Front Immunol. 2022; 13:877558.
PMID: 35865530 PMC: 9295749. DOI: 10.3389/fimmu.2022.877558.